Submitted by Nicola-Swanborough on Mon, 12/02/2018 - 17:03
New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).
Submitted by Nicola-Swanborough on Tue, 06/02/2018 - 15:21
Epilepsy Society's chief executive Clare Pelham explains why mothers who have campaigned relentlessly about equality in women's health, are her inspiration as we celebrate #VotesforWomen
Submitted by Nicola-Swanborough on Thu, 26/10/2017 - 13:31
Our content manager, Nicola Swanborough, explains how our sodium valproate survey helped us raise awareness of risks associated with the drug in the media, parliament and with Government.
Submitted by Nicola-Swanborough on Wed, 18/10/2017 - 13:13
Arlene Foster, leader of the Democratic Unionist Party and First Minister of Northern Ireland has pledged her support for Epilepsy Society's campaign to ensure mandatory reviews for all women and girls of childbearing who take sodium valproate.
Submitted by Nicola-Swanborough on Tue, 17/10/2017 - 12:26
Epilepsy Society's chief executive, Clare Pelham, receives a response from health secretry Jeremy Hunt about safety issues around epilepsy drug, sodium valproate.
Submitted by Nicola-Swanborough on Mon, 16/10/2017 - 15:11
This Thursday (19 October 2017), MPs will be meeting in the House of Commons to debate safety issues around the epilepsy drug sodium valproate.
Submitted by Nicola-Swanborough on Thu, 13/07/2017 - 11:02
Women and girls of childbearing age who are taking or have taken sodium valproate, are being invited to apply to take part in a public hearing about the epilepsy drug.
Submitted by helen-skipworth on Tue, 08/11/2016 - 15:14
Almost half (48%) of women with epilepsy are unaware of the risks of taking epilepsy medicine sodium valproate, according to a new survey by three leading UK epilepsy charities.
Submitted by helen-skipworth on Mon, 31/10/2016 - 11:56
One in five women currently taking the epilepsy drug, sodium valproate, do not know that it can cause developmental problems or birth defects in an unborn child.
Submitted by Nicola-Swanborough on Mon, 24/10/2016 - 16:20
Sodium valproate should not be prescribed to women with epilepsy who are of child bearing age,unless there has been a full discussion of the potential risks and benefits to the woman and any future unborn child, warn medics.